ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P951. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,151,772 | +6.7% | 12,300 | +1.7% | 0.00% | +33.3% |
| Q2 2023 | $1,079,925 | +215.8% | 12,100 | +332.1% | 0.00% | +200.0% |
| Q4 2022 | $341,964 | -55.8% | 2,800 | -62.7% | 0.00% | -50.0% |
| Q3 2022 | $774,000 | +11.0% | 7,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $697,000 | +1383.0% | 7,500 | +1775.0% | 0.00% | – |
| Q1 2022 | $47,000 | +74.1% | 400 | +100.0% | 0.00% | – |
| Q4 2021 | $27,000 | -15.6% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $32,000 | -72.9% | 200 | -77.8% | 0.00% | – |
| Q2 2021 | $118,000 | +126.9% | 900 | +125.0% | 0.00% | – |
| Q1 2021 | $52,000 | +57.6% | 400 | +100.0% | 0.00% | – |
| Q4 2020 | $33,000 | -95.9% | 200 | -96.2% | 0.00% | -100.0% |
| Q3 2020 | $802,000 | +6.4% | 5,200 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $754,000 | +6754.5% | 5,100 | +5000.0% | 0.00% | – |
| Q1 2020 | $11,000 | -60.7% | 100 | -50.0% | 0.00% | – |
| Q4 2019 | $28,000 | -70.8% | 200 | -80.0% | 0.00% | -100.0% |
| Q3 2019 | $96,000 | -97.7% | 1,000 | -97.2% | 0.00% | -97.3% |
| Q2 2019 | $4,134,000 | +34.6% | 35,900 | +37.5% | 0.04% | +8.8% |
| Q1 2019 | $3,072,000 | +1342.3% | 26,100 | +667.6% | 0.03% | +1600.0% |
| Q4 2018 | $213,000 | +2942.9% | 3,400 | +3300.0% | 0.00% | – |
| Q3 2018 | $7,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 36,800 | $3,421,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 7,500 | $697,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,600 | $334,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |